140 related articles for article (PubMed ID: 17441926)
1. Signal-transduction inhibitors in renal cell carcinoma.
Vogelzang NJ; Sternberg CN
BJU Int; 2007 May; 99(5 Pt B):1289-95. PubMed ID: 17441926
[No Abstract] [Full Text] [Related]
2. A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma.
Hutson TE; Bukowski RM
Clin Genitourin Cancer; 2006 Mar; 4(4):296-8. PubMed ID: 16729915
[No Abstract] [Full Text] [Related]
3. Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
Yagoda A; Abi-Rached B; Petrylak D
Semin Oncol; 1995 Feb; 22(1):42-60. PubMed ID: 7855619
[No Abstract] [Full Text] [Related]
4. Re: E. Jason Abel, Stephen H. Culp, Nizar M. Tannir, et al. Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol 2011;59:10-5.
Ozcan MF; Canda AE; Dizdar O; Altinova S; Akbulut Z; Balbay MD
Eur Urol; 2011 Jun; 59(6):e34. PubMed ID: 21398023
[No Abstract] [Full Text] [Related]
5. Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
Carver BS
J Urol; 2009 Sep; 182(3):833-4. PubMed ID: 19616224
[No Abstract] [Full Text] [Related]
6. Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma.
Sonpavde G; Hutson TE; Sternberg CN
Expert Opin Investig Drugs; 2008 Feb; 17(2):253-61. PubMed ID: 18230058
[TBL] [Abstract][Full Text] [Related]
7. Will the dark sky over advanced renal cell carcinoma soon become brighter?
D'Hondt V; Gil T; Lalami Y; Piccart M; Awada A
Eur J Cancer; 2005 Jun; 41(9):1246-53. PubMed ID: 15939260
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and prognosis in advanced renal cell carcinoma.
Galsky MD; Vogelzang NJ
Expert Rev Anticancer Ther; 2007 Jun; 7(6):839-45. PubMed ID: 17555394
[TBL] [Abstract][Full Text] [Related]
9. [Application monitoring of the use of sorafenib in papillary renal cell carcinoma].
Schrader AJ; Hegele A; Olbert P; Buer J; Jeron A; Hofmann R
Urologe A; 2007 Sep; 46(9):1291. PubMed ID: 17668165
[No Abstract] [Full Text] [Related]
10. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
Kirkali Z
Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
[No Abstract] [Full Text] [Related]
11. Pazopanib: an oral multitargeted tyrosine kinase inhibitor for use in renal cell carcinoma.
LaPlant KD; Louzon PD
Ann Pharmacother; 2010 Jun; 44(6):1054-60. PubMed ID: 20407031
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of renal cell carcinoma: 1983-1989.
Yagoda A
Semin Urol; 1989 Nov; 7(4):199-206. PubMed ID: 2694257
[No Abstract] [Full Text] [Related]
13. Temsirolimus (Torisel) for advanced renal cell carcinoma.
Med Lett Drugs Ther; 2007 Dec; 49(1276):103-4. PubMed ID: 18084154
[No Abstract] [Full Text] [Related]
14. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.
Malizzia LJ; Hsu A
Clin J Oncol Nurs; 2008 Aug; 12(4):639-46. PubMed ID: 18676330
[TBL] [Abstract][Full Text] [Related]
15. Treatment for renal cancer: are we beyond the cytokine era?
Ramsey S; Aitchison M
Nat Clin Pract Urol; 2006 Sep; 3(9):478-84. PubMed ID: 16964189
[TBL] [Abstract][Full Text] [Related]
16. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
17. [Clinical results of Nexavar for the treatment of kidney cancer].
Escudier B
Prog Urol; 2007 Feb; 17(1 Suppl 1):150-3. PubMed ID: 17571640
[No Abstract] [Full Text] [Related]
18. Temsirolimus in renal cell carcinoma.
Otto T; Eimer C; Gerullis H
Transplant Proc; 2008 Dec; 40(10 Suppl):S36-9. PubMed ID: 19100905
[TBL] [Abstract][Full Text] [Related]
19. Managing refractory metastatic renal cell carcinoma: a RECORD spinning on a tilted AXIS.
Pal SK; Vogelzang NJ
Clin Genitourin Cancer; 2011 Sep; 9(1):3-5. PubMed ID: 21816688
[No Abstract] [Full Text] [Related]
20. Novel therapeutics for metastatic renal cell carcinoma.
Hutson TE; Figlin RA
Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
